Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection

被引：1

作者：

Muinonen-Martin, Andy ^{[1
]}

Lee, Rebecca ^{[2
,3
]}

Rothwell, Dominic ^{[4
]}

Jackson, Richard ^{[5
]}

Smith, Nigel ^{[4
]}

Wong, Stephen ^{[6
,7
]}

Kelso, Noel ^{[4
]}

Hewitt, Chelsee ^{[6
]}

Mitchell, Jackie ^{[4
]}

Jones, Kate ^{[6
]}

Turajlic, Samra ^{[8
]}

Corrie, Pippa ^{[9
]}

Marais, Richard ^{[10
]}

Middleton, Mark ^{[11
]}

Dawson, Sarah-Jane ^{[6
,7
,12
]}

Sandhu, Shahneen ^{[6
,7
]}

Dive, Caroline ^{[4
]}

Lorrigan, Paul ^{[2
]}

机构：

[1] Leeds Teaching Hosp NHS Trust, Leeds, England

[2] Christie NHS Fdn Trust, Manchester, England

[3] Div Canc Sci, Manchester, Lancs, England

[4] Canc Res UK Manchester Inst, Canc Biomarker Ctr, Manchester, Lancs, England

[5] Univ Liverpool, Liverpool Clin Trials Unit, Liverpool, England

[6] Peter MacCallum Canc Ctr, Melbourne, Australia

[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia

[8] Royal Marsden Hosp, Dept Med Oncol, London, England

[9] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[10] Univ Manchester, Manchester Inst, Mol Oncol Grp, Canc Biomarker Ctr, Manchester, England

[11] Churchill Hosp, Dept Med Oncol, Oxford, England

[12] Univ Melbourne, Ctr Canc Res, Melbourne, Australia

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

D O I：

10.1093/bjd/ljad113.084

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P56

引用

页数：1

共 50 条

[1] DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection.
Lee, Rebecca
Rothwell, Dominic G.
Jackson, Richard
Smith, Nigel
Wong, Stephen Q.
Kelso, Noel
Burghel, George
Hewitt, Chelsee
Clarke, Harry
Mitchell, Jackie
Jones, Kate
Muinonen-Martin, Andrew
Turajlic, Samra
Corrie, Philippa Gail
Marais, Richard
Middleton, Mark R.
Dawson, Sarah-Jane
Sandhu, Shahneen
Dive, Caroline
Lorigan, Paul
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
Timothy J. Vreeland
Guy T. Clifton
Diane F. Hale
Robert C. Chick
Annelies T. Hickerson
Jessica L. Cindass
Alexandra M. Adams
Phillip M. Kemp Bohan
Robert H. I. Andtbacka
Adam C. Berger
James W. Jakub
Jeffrey J. Sussman
Alicia M. Terando
Thomas Wagner
George E. Peoples
Mark B. Faries
Annals of Surgical Oncology, 2021, 28 : 6126 - 6137
[3] A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
Vreeland, Timothy J.
Clifton, Guy T.
Hale, Diane F.
Chick, Robert C.
Hickerson, Annelies T.
Cindass, Jessica L.
Adams, Alexandra M.
Bohan, Phillip M. Kemp
Andtbacka, Robert H. I.
Berger, Adam C.
Jakub, James W.
Sussman, Jeffrey J.
Terando, Alicia M.
Wagner, Thomas
Peoples, George E.
Faries, Mark B.
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6126 - 6137
[4] Circulating tumour DNA analysis predicts relapse following resection in stage II and III melanoma
Tan, L.
Sandhu, S. K.
Lee, R.
Li, J.
Callahan, J.
Raleigh, J.
Hatzimihalis, A.
Middlehurst, P.
Henderson, M.
Shackleton, M.
Haydon, A.
Gyorki, D.
Oudit, D.
Hicks, R. J.
Lorigan, P.
McArthur, G. A.
Marais, R.
Wong, S. Q.
Dawson, S-J.
ANNALS OF ONCOLOGY, 2018, 29
[5] Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma
Hoshimoto, Sojun
Faries, Mark B.
Morton, Donald L.
Shingai, Tatsushi
Kuo, Christine
Wang, He-jing
Elashoff, Robert
Mozzillo, Nicola
Kelley, Mark C.
Thompson, John F.
Lee, Jeffrey E.
Hoon, Dave S. B.
ANNALS OF SURGERY, 2012, 255 (02) : 357 - 362
[6] A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update
Biswas, S.
Wrigley, J.
East, C.
Hern, A.
Marshall, A.
Dunn, J.
Lorigan, P.
Middleton, M.
Corrie, P.
ECANCERMEDICALSCIENCE, 2008, 2
[7] IPILIMUMAB VERSUS PLACEBO AFTER COMPLETE RESECTION OF STAGE III MELANOMA: EFFICACY AND SAFETY RESULTS FROM THE EORTC 18071 PHASE III TRIAL
Eggermont, Alexander M.
Chiarion-Sileni, Vanna
Grob, Jean J.
Dummer, Reinhard
Wolchok, Jedd D.
Schmidt, Henrik
Hamid, Omid
Robert, Caroline
Ascierto, Paolo A.
Richards, Jon M.
Ferraresi, Virginia
Smylie, Michael
Weber, Jeff S.
Maio, Michele
Konto, Cyril
de Pril, Veerle
Suciu, Stefan
Testori, Alessandro
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 175 - 175
[8] CONCURRENT CHEMORADIOTHERAPY FOLLOWED BY SURGICAL RESECTION FOR STAGE III THYMIC TUMORS - EARLY RESULT OF A PHASE II PROSPECTIVE CLINICAL TRIAL
Wang, Changlu
Fang, Wentao
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : 44 - 45
[9] Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: Updated results from a phase III trial (CheckMate 238).
Weber, Jeffrey S.
Mandala, Mario
Del Vecchio, Michele
Gogas, Helen
Arance, Ana M.
Cowey, Charles Lance
Dalle, Stephane
Schenker, Michael
Chiarion-Sileni, Vanna
Rodas, Ivan Marquez
Grob, Jean-Jacques
Butler, Marcus
Middleton, Mark R.
Maio, Michele
Atkinson, Victoria
Dummer, Reinhard
de Pril, Veerle
Qureshi, Anila H.
Larkin, James M. G.
Ascierto, Paolo Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[10] Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial
Bol, Kalijn F.
Schreibelt, Gerty
Bloemendal, Martine
van Willigen, Wouter W.
Bree, Simone Hins-de
de Goede, Anna L.
de Boer, Annemiek J.
Bos, Kevin J. H.
Boer, Tjitske Duiveman-de
Nordkamp, Michel A. M. Olde
van Oorschot, Tom G. M.
Popelier, Carlijn J.
Pots, Jeanne M.
Scharenborg, Nicole M.
van de Rakt, Mandy W. M. M.
de Ruiter, Valeska
van Meeteren, Wilmy S.
van Rossum, Michelle M.
Croockewit, Sandra J.
Koeneman, Bouke J.
Creemers, Jeroen H. A.
Wortel, Inge M. N.
Angerer, Caroline
Bruening, Mareke
Petry, Katja
Dzionek, Andrzej
van der Veldt, Astrid A.
van Gruenhagen, Dirk J.
Werner, Johanna E. M.
Bonenkamp, Johannes J.
Haanen, John B. A. G.
Boers-Sonderen, Marye J.
Koornstra, Rutger H. T.
Boomsma, Martijn F.
Aarntzen, Erik H. J.
Gotthardt, Martin
Nagarajah, James
de Witte, Theo J. M.
Figdor, Carl G.
de Wilt, Johannes H. W.
Textor, Johannes
de Groot, Jan Willem B.
Gerritsen, Winald R.
de Vries, I. Jolanda M.
NATURE COMMUNICATIONS, 2024, 15 (01)

← 1 2 3 4 5 →